PropertyValue
?:abstract
  • Recent papers in the Journal provide tangible avenues for COVID‐19 vaccine production as immunoreactive epitopes are brought to the forefront in these and many other emerging studies.(1,2) The development of a consistent predictable animal model of COVID‐19 infection is evidently also a welcome event for preliminary antiviral and vaccine assessments and surely brings us to another level of progression.(3) This article is protected by copyright. All rights reserved.
?:creator
?:doi
  • 10.1002/jmv.25876
?:doi
?:journal
  • J_Med_Virol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/74d7b0b9bd5108a31282c958022bd80697cc3053.json
?:pmcid
?:pmid
?:pmid
  • 32285942.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Defining Protective Epitopes for COVID‐19 Vaccination Models
?:type
?:year
  • 2020-04-14

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/77mw0dws>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/77mw0dws>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all